key: cord-0947048-biyu5o4f
authors: Abbasi-Oshaghi, Ebrahim; Mirzaei, Fatemeh; Khodadadi, Iraj
title: Letter to the Editor Regarding ‘COVID-19 and diabetes: What does the clinician need to know?’
date: 2020-11-02
journal: Prim Care Diabetes
DOI: 10.1016/j.pcd.2020.10.010
sha: c335008280a202367f53d85727457d8ff34037d9
doc_id: 947048
cord_uid: biyu5o4f

nan

Dear Editor,

We are writing with reference to recent article published in your journal by Papadokostaki et al [1] . Certainly, we agree with the association of diabetes with coronavirus disease 2019 (COVID-19). However, the proposed mechanisms and its relationship with pneumonia are not fully presented.

Pneumonia is a main cause of morbidity and mortality of COVID-19 infection. Previous studies have been reported that diabetic patients are at risk of infections, particularly influenza and pneumonia. Diabetes decreases the clearance of bacteria from the lung and reduces the phagocytic ability of granulocyte cells. Increased blood glucose levels, as a result of uncontrolled diabetes, could stimulate bacterial growth by increasing the interaction of the bacteria with lung epithelium [2] . Hyperglycemia can deteriorate lung function and structure by different pathways, including oxidative stress (OS), decreased leukocyte function, impaired elastic recoil, reduced muscle strength, induced inflammation, and increased protein glycosylation (e.g., advanced glycation end-product) [3] . Lung has an elastic architecture and hyperglycemia affect elastic proteins of the lung. This organ is a place of highest contact with oxygen and OS. Diabetes leads to alteration in the pulmonary vasculature and pulmonary microangiopathy, which may be accounted for reducing CO diffusion capacity and pulmonary capillary blood volume [3] .

The binding of advanced glycation end products (AGEs) to its receptor leads to OS, inflammation, and apoptosis in lung cells. High levels of AGEs formation occur in poorly controlled diabetic subjects. Carboxymethyl lysine is the main AGEs in human serum, and its production increased in conditions related to inflammation and lung injury. It has been reported that binding of AGEs to its receptor, induces the production of inflammatory factors such as nuclear factor-κB cascade which probably increases the risk of pneumonia. AGEs are

Covid-19 and diabetes: What does the clinician need to know?

Importance of hyperglycemia in preoperative, intraoperative and postoperative periods in covid-19 patients

Diabetes and respiratory system including tuberculosis -challenges

Receptor for advanced glycation end products is detrimental during influenza a virus pneumonia